Provided by Tiger Trade Technology Pte. Ltd.

Nextcure Inc.

5.95
+0.04000.68%
Volume:17.02K
Turnover:99.57K
Market Cap:27.24M
PE:-0.58
High:6.09
Open:5.90
Low:5.65
Close:5.91
52wk High:15.74
52wk Low:1.55
Shares:4.58M
Float Shares:2.94M
Volume Ratio:0.56
T/O Rate:0.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-10.2671
EPS(LYR):-19.6464
ROE:-204.56%
ROA:-69.02%
PB:2.24
PE(LYR):-0.30

Loading ...

NextCure Initiated at Buy by LUCID CAPITAL MARKETS

Dow Jones
·
May 12

NextCure publishes corporate presentation on Phase 1 antibody-drug conjugate cancer programs

Reuters
·
May 08

NextCure Q1 EPS $(1.87) Beats $(2.12) Estimate

Benzinga Earnings
·
May 08

NextCure Q1 net loss narrows to $9.8 million

Reuters
·
May 08

BRIEF-NextCure Q1 Net Income USD -9.796 Million

Reuters
·
May 08

NextCure starts Phase 1 dose optimization study of SIM0505 in platinum-resistant ovarian cancer

Reuters
·
May 04

NextCure and Simcere Zaiming Initiate Dose Optimization for Sim0505 (Cdh6 ADC) in Gynecologic Cancers

THOMSON REUTERS
·
May 04

NextCure - Accelerating Development of Program by Expanding Our Clinical Site Footprint Into Canada and Europe

THOMSON REUTERS
·
May 04

NextCure - Accelerating Development of Program by Increasing Number of U.S. and China Trial Sites

THOMSON REUTERS
·
May 04

NextCure Inc expected to post a loss of $1.81 a share - Earnings Preview

Reuters
·
Apr 27

NextCure announces annual shareholder meeting to be held virtually

Reuters
·
Apr 25

NextCure, Simcere to present Phase 1 SIM0505 solid tumor data at ASCO 2026

Reuters
·
Apr 21

NextCure wins FDA Fast Track for SIM0505 in platinum-resistant ovarian cancer

Reuters
·
Apr 07

NextCure Receives Fast Track Designation for Sim0505 (Cdh6 ADC) in Ovarian Cancer

THOMSON REUTERS
·
Apr 07

NextCure, Simcere CDH6 ADC abstract accepted for ASCO meeting

Reuters
·
Apr 01

NextCure Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Mar 06

NextCure Publishes Corporate Presentation on Targeted ADC Cancer Therapies

Reuters
·
Mar 06

NextCure reports marginal increase in 2025 net loss

Reuters
·
Mar 06

NextCure Q4 EPS $(0.81) Beats $(2.42) Estimate

Benzinga Earnings
·
Mar 06

NextCure trading halted, volatility trading pause

TIPRANKS
·
Mar 02